Perspectives

Life Sciences Connect

Our podcast series on the Life Sciences Industry

Life Sciences Connect explores the big issues, the emerging trends and the cutting edge innovations that are shaping the Life Sciences Industry. Each month, we will connect with industry experts and leaders from the Biotech, Pharmaceutical and Medical Devices industries to discuss how key trends, explored in our research reports, are charting a new, sustainable future for the Life Sciences Industry.

Episode #11: How can AI play a critical role in the Biopharma commercial model?
Our eleventh episode of the Life Sciences Connect series explores the critical role AI plays in Biopharma launch and commercial activities.

Listen now
Episode #10: Seeds of change for pharma R&D returns
Our tenth episode of Life Sciences Connect series explores our latest insights on pharma R&D productivity including the impact and learnings from the pandemic.

Listen now
Episode #9: What is driving MedTech’s transformation?
Our ninth episode of Life Sciences Connect series explores the key trends for the MedTech industry including the rise in consumer organisations entering the space, the evolution from product to service, the changing regulatory landscape, and the acceleration of MedTech in healthcare because of COVID-19.

Listen now
Episode #8: James Gregson on trends transforming life sciences and healthcare
In our eighth episode of Life Sciences Connect, we talk to Deloitte’s new Life Sciences and Healthcare leader James Gregson on what he hopes to accomplish in his new role, tips for managing work and family life along with his views on the trends transforming the industry.

Listen now
Episode #7: The future unmasked - Predicting the future of healthcare and life sciences in 2025
In the seventh episode of Life Sciences Connect, we discuss what the future holds for Life Sciences and Healthcare in 2025.

Listen now
Episode #6: Real World Evidence
Our sixth podcast looks at the impact Real World Evidence has on biopharma companies, how best to implement knowledge management systems to maximise Real World Data (RWD), the importance of change management and the role skills and talent has in maximising value from RWD.

Listen now
Episode #5: Digital transformation in healthcare
Our fifth podcast looks at the key issue of digital transformation of the healthcare systems across Europe, and the impact COVID-19 has had on accelerating progress. We discuss the findings of our report, Shaping the future of European healthcare, and get insights from those already providing digital healthcare services.

Listen now
Episode #4: Scaling Biotech companies in challenging times
The Biotech sector is a key player in driving biopharma innovation and developing ground-breaking treatments for patients. Supporting the growth of this sector is vital to ensure that R&D efforts continue, both now and in the future. However, like most industries, this sector faces a complex set of challenges. In the fourth episode of Life Sciences Connect, we explore these challenges and the opportunities facing the Biotech Industry.

Listen now
Episode #3: Transforming Drug Supply Chains
The COVID-19 pandemic has brought unprecedented challenges, highlighting the limitations of traditional linear supply chains and acting as a catalyst for the acceleration of digital transformation. In the third episode of Life Sciences Connect, we explore digital transformation of biopharma supply chains and adoption of artificial intelligence.

Listen now
Episode #2: The Future of Health
In the second episode of Life Sciences Connect, we explore how the COVID-19 pandemic has accelerated the move towards the Future of Health, where technology and data enable health care that is more personalised, predictive, preventative and participatory.

Listen now
Episode #1: Artificial Intelligence in Clinical Trials
For our first episode, we explore the use of Artificial Intelligence in clinical trials and how regulators are embracing new technologies. The current COVID-19 pandemic has caused widespread disruption to ongoing clinical trials. In response, regulatory bodies have issued patient safety-focused guidance advising sponsors to employ a risk-based approach to implementing COVID-19 contingency plans.

Listen now

Did you find this useful?